Total Payments
$3,288
2024 Payments
$692.19
Companies
15
Transactions
58
Medicare Patients
886
Medicare Billing
$92,619
Payment Breakdown by Category
Food & Beverage$3,288 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,288 | 58 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $716.20 | 13 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $674.28 | 8 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $432.31 | 4 | $0 (2023) |
| Esperion Therapeutics, Inc. | $350.09 | 4 | $0 (2022) |
| ABBVIE INC. | $273.28 | 8 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $149.49 | 2 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $127.94 | 6 | $0 (2023) |
| Lilly USA, LLC | $125.00 | 1 | $0 (2022) |
| Phathom Pharmaceuticals, Inc. | $124.55 | 1 | $0 (2024) |
| Abbott Laboratories | $119.15 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $692.19 | 14 | ABBVIE INC. ($225.98) |
| 2023 | $746.40 | 19 | AstraZeneca Pharmaceuticals LP ($400.67) |
| 2022 | $560.67 | 10 | Lilly USA, LLC ($125.00) |
| 2021 | $372.55 | 4 | Boehringer Ingelheim Pharmaceuticals, Inc. ($230.72) |
| 2020 | $241.57 | 3 | AstraZeneca Pharmaceuticals LP ($125.01) |
| 2019 | $223.82 | 2 | Novartis Pharmaceuticals Corporation ($223.82) |
| 2018 | $315.08 | 3 | Novartis Pharmaceuticals Corporation ($315.08) |
| 2017 | $135.38 | 3 | Novartis Pharmaceuticals Corporation ($135.38) |
All Payment Transactions
58 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: Diabetes | ||||||
| 11/09/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Biological | ||||||
| 11/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $124.55 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: NEUROSCIENCE | ||||||
| 10/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Diabetes | ||||||
| 06/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $122.50 | General |
| Category: NEUROSCIENCE | ||||||
| 06/14/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: PSYCHIATRY | ||||||
| 06/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Diabetes | ||||||
| 05/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $124.55 | General |
| Category: Respiratory | ||||||
| 05/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: NEUROSCIENCE | ||||||
| 05/01/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Diabetes | ||||||
| 04/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: NEUROSCIENCE | ||||||
| 02/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: NEUROSCIENCE | ||||||
| 01/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: NEUROSCIENCE | ||||||
| 11/17/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/14/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: Cardio-renal | ||||||
| 09/22/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.90 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Respiratory | ||||||
| 08/31/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $104.94 | General |
| Category: DIABETES | ||||||
| 07/27/2023 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 07/14/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Respiratory | ||||||
| 07/08/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Cardio-renal | ||||||
| 06/30/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $23.06 | General |
| Category: Cardiovascular | ||||||
| 06/23/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: Biological | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 161 | 372 | $180,230 | $21,598 |
| 2022 | 5 | 189 | 370 | $160,422 | $19,036 |
| 2021 | 7 | 269 | 517 | $223,319 | $25,653 |
| 2020 | 7 | 267 | 526 | $226,839 | $26,333 |
Total Patients
886
Total Services
1,785
Medicare Billing
$92,619
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 84 | 253 | $106,007 | $11,735 | 11.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 29 | 67 | $40,736 | $5,863 | 14.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 13 | $13,286 | $1,736 | 13.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 23 | $13,593 | $1,275 | 9.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 12 | 16 | $6,608 | $989.76 | 15.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 86 | 213 | $81,153 | $8,933 | 11.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 32 | 84 | $46,452 | $6,660 | 14.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 45 | 45 | $24,165 | $2,200 | 9.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 12 | 14 | $5,250 | $802.40 | 15.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 14 | 14 | $3,402 | $441.17 | 13.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 46 | 130 | $69,810 | $10,537 | 15.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 107 | 250 | $92,467 | $7,294 | 7.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 55 | 55 | $28,655 | $2,688 | 9.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 12 | 13 | $13,286 | $2,317 | 17.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 16 | 25 | $9,100 | $1,408 | 15.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 18 | 25 | $5,525 | $1,020 | 18.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 15 | 19 | $4,476 | $388.22 | 8.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 58 | 169 | $88,049 | $13,715 | 15.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 106 | 241 | $86,499 | $5,779 | 6.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 21 | 21 | $20,832 | $3,485 | 16.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 24 | 29 | $10,237 | $1,610 | 15.7% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 26 | 26 | $13,141 | $747.84 | 5.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 15 | 16 | $2,510 | $569.76 | 22.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 17 | 24 | $5,571 | $426.90 | 7.7% |
About Dr. Marwan Hilal, M.D
Dr. Marwan Hilal, M.D is a Internal Medicine healthcare provider based in Bedford, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1154308781.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marwan Hilal, M.D has received a total of $3,288 in payments from pharmaceutical and medical device companies, with $692.19 received in 2024. These payments were reported across 58 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($3,288).
As a Medicare-enrolled provider, Hilal has provided services to 886 Medicare beneficiaries, totaling 1,785 services with total Medicare billing of $92,619. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Bedford, OH
- Active Since 12/24/2005
- Last Updated 10/29/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1154308781
Products in Payments
- ENTRESTO (Drug) $674.28
- JARDIANCE (Drug) $557.31
- NEXLIZET (Drug) $343.17
- BREZTRI (Drug) $322.71
- VRAYLAR (Drug) $273.28
- GVOKE HYPOPEN (Drug) $149.49
- FARXIGA (Drug) $143.93
- Kerendia (Drug) $127.94
- LOKELMA (Drug) $125.01
- AIRSUPRA (Drug) $124.55
- VOQUEZNA (Drug) $124.55
- XIENCE SIERRA (Device) $119.15
- ELIQUIS (Drug) $70.23
- Veozah (Drug) $41.30
- PAXLOVID (Drug) $34.02
- Ozempic (Drug) $33.10
- CAPLYTA (Drug) $16.72
- NEXLETOL (Drug) $6.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bedford
Dr. Michael Delaughter, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $1.7M
Internal Medicine $1.7M
Scott Greenberg, Md, MD
Internal Medicine — Payments: $171,246
Internal Medicine $171,246
Dr. Venkatesan Vidi, M.d., M.p.h, M.D., M.P.H
Internal Medicine — Payments: $17,343
Internal Medicine $17,343
Dr. Elmer Smith, Md, MD
Internal Medicine — Payments: $17,311
Internal Medicine $17,311
Paul Kim, Md, MD
Internal Medicine — Payments: $15,775
Internal Medicine $15,775
Alisa Thamwiwat, M.d, M.D
Internal Medicine — Payments: $13,867
Internal Medicine $13,867